CUBE vs PFE · P/E 25, rev $1.07B vs P/E 20, rev $62.58B
CubeSmart (CUBE) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CUBE and PFE stock pages for the full models.
Not investment advice.